Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222644 · ClinicalTrials.gov registry record · NA
Clinical Language Evaluation With AI for Residents
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT07222644: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT07222644 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222644, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to refine and test existing enterprise-grade large language model (LLM) based on generative artificial intelligence (AI), to assess the feasibility and acceptability of LLM-based feedback, to assess the ability of LLM-based feedback to improve residents' communications,to explore the ability of standardized patients to assess residents' communication and to explore the ability of residents to self-assess their communication complexity
Primary Outcome
This will be scored by the by Cohen's Kappa values from 1-5. Higher Cohen's kappa scores mean better outcome
Interventions
- BEHAVIORAL educational LLM-based feedback tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-10-23 |
| Est. Completion | 2026-05-28 |
| Phase | NA |
What is known before NCT07222644 opens enrollment
NCT07222644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which educational LLM-based feedback tool is the first listed.
NCT07222644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07222644 about?
NCT07222644 is a clinical study titled "Clinical Language Evaluation With AI for Residents". The purpose of this study is to refine and test existing enterprise-grade large language model (LLM) based on generative artificial intelligence (AI), to assess the feasibility and acceptability of LLM-based feedback, to assess the ability of LLM-based feedback to improve residents' communications,t...
What is the current status of trial NCT07222644?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2025-10-23. Estimated completion is 2026-05-28.
What interventions are being tested in trial NCT07222644?
The interventions under investigation include: educational LLM-based feedback tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT07222644?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07222644's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI